{"id":361,"date":"2016-10-01T13:43:55","date_gmt":"2016-10-01T11:43:55","guid":{"rendered":"https:\/\/www.myopiacare.org\/fr\/about-us\/"},"modified":"2020-04-16T20:28:17","modified_gmt":"2020-04-16T18:28:17","slug":"a-propos1","status":"publish","type":"page","link":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/","title":{"rendered":"A propos"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n
\n

Pascal Blaser<\/strong> et Nick Dash<\/strong> sont les concepteurs de \u2018myopia.care\u2019<\/strong> et ont \u0153uvr\u00e9 \u00e0 la r\u00e9alisation de ce projet innovant. A travers \u2018myopia.care\u2019<\/strong>, ils ont cr\u00e9\u00e9 un syst\u00e8me permettant de r\u00e9duire l\u2019impact de l\u2019 \u00ab\u00a0\u00e9pid\u00e9mie de myopie\u00a0\u00bb<\/strong>.<\/h4>\n

Actuellement, la plupart des professionnels de la sant\u00e9 oculaire suivent l\u2019augmentation continuelle de la myopie, ann\u00e9e apr\u00e8s ann\u00e9e, sans cependant consid\u00e9rer les m\u00e9thodes qui pourraient ralentir sa progression<\/strong><\/span>.<\/h4>\n

La science moderne nous a pourtant donn\u00e9 des outils permettant de freiner l\u2019\u00e9volution<\/strong><\/span> cette anomalie oculaire et il est de notre devoir envers nos patients de les utiliser.<\/h4>\n

Notre mission<\/strong> est de briser les obstacles qui bloquent l\u2019adoption de ces nouvelles strat\u00e9gies de contr\u00f4le de la myopie<\/span><\/strong>. Pour y arriver, nous croyons que la mise en place d\u2019un dialogue coh\u00e9rent entre patient et professionnel est indispensable. A chaque \u00e9tape du processus, la science et l\u2019\u00e9ducation tiennent une place primordiale. \u00a0<\/h4>\n

Nous y parvenons en cr\u00e9ant le contact entre le patient (l\u2019enfant et ses parents) et les sp\u00e9cialistes \u2018myopia.care\u2019<\/strong>. Nous conseillons et fournissons \u00e0 nos sp\u00e9cialistes les techniques scientifiquement prouv\u00e9es comme \u00e9tant efficaces pour contr\u00f4ler la myopie*.<\/h4>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n

* le contr\u00f4le effectif est consid\u00e9r\u00e9 par de nombreux cliniciens pour \u00eatre sup\u00e9rieure \u00e0 50% de r\u00e9duction de la progression de la myopie.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
[siteorigin_widget class=\u00a0\u00bbSiteOrigin_Widget_Headline_Widget\u00a0\u00bb][\/siteorigin_widget]<\/div>\n<\/div>\n
[siteorigin_widget class=\u00a0\u00bbSiteOrigin_Widget_Image_Widget\u00a0\u00bb][\/siteorigin_widget]<\/div>\n
\n
\n
\n
\n

M.Sc. of \u00a0Vision Science and Business (Optometry)<\/em><\/span><\/h4>\n

Specialist optometrist and new media geek\u00a0<\/span><\/h3>\n

Pascal Blaser is a contact lens specialist Optometrist with 10 years experience in the contact lens industry. He has developed various designs for contact lenses to improve the visual quality from wearers.<\/p>\n

He is currently working in the management of an independent custom made contact lens manufacturer in Switzerland. Pascal Blaser has presented lectures about contact lenses in Europe and the Middle East to improve the skills of eye care specialists. Additionally, he is hosting several websites in different sectors.<\/p>\n

This passion for eye care and new media platforms gave him the idea to create a simple and useful tool to help the affected patient and support the specialist in their daily practice.<\/p>\n

\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
[siteorigin_widget class=\u00a0\u00bbSiteOrigin_Widget_Headline_Widget\u00a0\u00bb][\/siteorigin_widget]<\/div>\n<\/div>\n
[siteorigin_widget class=\u00a0\u00bbSiteOrigin_Widget_Image_Widget\u00a0\u00bb][\/siteorigin_widget]<\/div>\n
\n
\n
\n
\n

BSc (Hons), MSc, FCOptom, PDipM.<\/h4>\n

Developing the future<\/h3>\n
Ross Grant is a founding partner of\u00a0ToolBox<\/a>\u00a0Training and Consultancy, based in Z\u00fcrich Switzerland. He is an optometrist who has worked in the optical industry for over 40 years in practice, research, marketing and general management. He believes that there are many challenges associated with the growing prevalence of myopia in the world, and in its prevention and management from both clinical and business aspects.<\/div>\n

 <\/p>\n

\"\"<\/a><\/div>\n
ToolBox<\/a>\u00a0provides business consultancy to the optical and pharmaceutical industries, specialising in organisational behaviour management, strategic restructuring, project management and compliance.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
[siteorigin_widget class=\u00a0\u00bbSiteOrigin_Widget_Headline_Widget\u00a0\u00bb][\/siteorigin_widget]<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
[siteorigin_widget class=\u00a0\u00bbSiteOrigin_Widget_Image_Widget\u00a0\u00bb][\/siteorigin_widget]<\/div>\n
\n
\n
\n
\n

OD, FBCLA<\/h4>\n

Dr. Thomas Aller<\/a>, OD, FBCLA graduated from UC Berkeley School of Optometry and for 27 years he has been researching the use of bifocal contacts for the control of myopia. After receiving the world\u2019s earliest patent for a method of myopia progression control, he spent ten very enjoyable years collaborating with Brien Holden and the Vision CRC on their anti-myopia program.<\/p>\n

Dr. Aller is currently conducting clinical trials on myopia management with an EDOF multifocal contact lens, as well as an anti-hyperopia multifocal lens design. He is also serving as a scientific and clinical advisor to TreeHouse Eyes. In 2016 he launched Myappia<\/a>, a myopia progression control progression app. Dr. Aller is also the editor of managemyopia.org. Dr. Aller is a Visiting Scholar at UC Berkeley and was also an Adjunct Professor at University of Houston and serves as a consultant and advisor to several companies working on myopia control contacts, spectacles and pharmaceuticals.<\/p>\n

Dr. Aller is also participating in the International Myopia Institute, dedicated to developing an authoritative consensus report on the myopia epidemic, its consequences and the recommended treatment approaches. Dr. Aller is the proud recipient of the 2018 Award of Excellence from the Global Specialty Lens Symposium.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

<\/div>\n
\n
[siteorigin_widget class=\u00a0\u00bbSiteOrigin_Widget_Image_Widget\u00a0\u00bb][\/siteorigin_widget]<\/div>\n
\n
\n
\n
\n

Optometrist UNSW, FIAOMC<\/h4>\n

Dr Oliver Woo (Orthokeratologist, Myopia Management Consultant) Graduated from School of Optometry, University of New South Wales, Australia in 1994 and established an independent Optometrist practice<\/a> in Sydney, Australia since 1997.<\/p>\n

His special interest are paediatric optometry, myopia prevention and control contact lens fitting with Orthokeratology and specialty contact lenses. Oliver Woo opened an Orthokeratology and Myopic Control Clinic in 2010. He become first Australian fellow of International Academy of Orthokeratology and Myopic Control (FIAOMC) and mentor in 2007 where he actively participate in the continuing education conference of the IAOA (International Academy of Orthokeratology Asian Section) as an instructor and mentor for FIAOMC of Chinese ophthalmologists. Since 2014 he is at Board of Director and Senior Member Examination coordinator and Examiner of Oceania Society of Orthokeratology (Australia and New Zealand). He is also since 2017 in the FIAO Executive Committee.<\/p>\n

Oliver Woo helping South East Asia countries optometrist associations in developing and organising Myopic Management programme and conferences and he lead the ub-Committee for Orthokeratology and Myopia Management of Asia Optometric Congress (AOC) and AOC Academy 2019<\/p>\n

In the last years he actively participate in many local and international optometry and ophthalmology conferences and as lecturers, mentors and coaches (over 60 international presentations).<\/p>\n

Watch his interview on ABC News on youtube.<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
[siteorigin_widget class=\u00a0\u00bbSiteOrigin_Widget_Image_Widget\u00a0\u00bb][\/siteorigin_widget]<\/div>\n
\n
\n
\n
\n

Optometrist FIACLE, FBCLA<\/h4>\n

Giancarlo Montani is Professor of Clinical Contact Lens Application at the University of Salento, Italy. Involved in Optometry education since 1988, he has been Department Head of the Contact Lens Division at the Santa Chiara University Medical Centre in\u00a0 Pisa, Italy until 2004.\u00a0 In 2007 Professor Giancarlo Montani has co-founded the Centre for contact lens research of the University of Salento.<\/p>\n

Giancarlo Montani also works in private practice. He has published numerous articles in optometric journals and has been invited as a lecturer to several national and international Optometry Congresses.<\/p>\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
<\/div>\n
\n
[siteorigin_widget class=\u00a0\u00bbSiteOrigin_Widget_Image_Widget\u00a0\u00bb][\/siteorigin_widget]<\/div>\n
\n
\n
\n
\n

BScHons(Optom) MCOptom ,Dip SVA.<\/em><\/span><\/h4>\n

Nick Dash is an Independent Clinical Optometrist with 30 years of varied experience and interest in a range of world-leading technologies to improve Global Eye Care.<\/p>\n

He is currently honorary lecturer at University of Wales, Cardiff whilst continuing his commercial interests and running educational events such as SkiCPD. Nick has lectured throughout the world from Harvard Medical School in the USA, to being invited 3 times by the Hong Kong Government to be Key Note Speaker on three separate occasions.<\/p>\n

Many of his peers regard Nick to be a Key Opinion Leader in Optometry, evident when asked to give a presentation at the BCLA \u201cVisionaries Meeting\u2019 at the Royal College of Physicians, London in 2015.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Pascal Blaser et Nick Dash sont les concepteurs de \u2018myopia.care\u2019 et ont \u0153uvr\u00e9 \u00e0 la r\u00e9alisation de ce projet innovant. A travers \u2018myopia.care\u2019, ils ont cr\u00e9\u00e9 un syst\u00e8me permettant de r\u00e9duire l\u2019impact de l\u2019 \u00ab\u00a0\u00e9pid\u00e9mie de myopie\u00a0\u00bb. Actuellement, la plupart des professionnels de la sant\u00e9 oculaire suivent l\u2019augmentation continuelle de la myopie, ann\u00e9e apr\u00e8s ann\u00e9e, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-361","page","type-page","status-publish","hentry"],"yoast_head":"\nA propos | myopia care<\/title>\n<meta name=\"description\" content=\"Pascal Blaser and Nick Dash have collaborated to form \u2018myopia.care\u2019 an innovative concept to implementation the risk analysis of children Near-sightednes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.myopiacare.org\/fr\/a-propos1\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Test your predicted Level of Myopia (Short-sightedness) with myopia.care\" \/>\n<meta property=\"og:description\" content=\"'myopia.care' offers a scientific approach to support a clinical pathway for children and young adults at risk of myopia or myopia progression, their parents and eye care professionals. Designed to limit the progression of myopia and its associated potential for sight threatening complications later in life. The web-based utility \u2018myopia.care\u2019 uses predictive myopia risk calculators and a guideline of recommended strategies based on over 50 published, peer reviewed papers and journals.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.myopiacare.org\/fr\/a-propos1\/\" \/>\n<meta property=\"og:site_name\" content=\"myopia care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/myopia.care\/\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-16T18:28:17+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.myopiacare.org\/wp-content\/uploads\/2016\/10\/kid-behind-table-large-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2129\" \/>\n\t<meta property=\"og:image:height\" content=\"882\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.myopiacare.org\/wp-content\/uploads\/2016\/10\/myopia-test-kid-behind-table.png\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/a-propos1\\\/\",\"url\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/a-propos1\\\/\",\"name\":\"A propos | myopia care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/a-propos1\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/a-propos1\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.myopiacare.com\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/Toolbox.png\",\"datePublished\":\"2016-10-01T11:43:55+00:00\",\"dateModified\":\"2020-04-16T18:28:17+00:00\",\"description\":\"Pascal Blaser and Nick Dash have collaborated to form \u2018myopia.care\u2019 an innovative concept to implementation the risk analysis of children Near-sightednes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/a-propos1\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/a-propos1\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/a-propos1\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.myopiacare.com\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/Toolbox.png\",\"contentUrl\":\"https:\\\/\\\/www.myopiacare.com\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/Toolbox.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/a-propos1\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A propos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/\",\"name\":\"myopia care\",\"description\":\"Test your Predicted Level of Myopia (Short-sightedness)\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/#organization\",\"name\":\"myopia.care\",\"url\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.myopiacare.org\\\/wp-content\\\/uploads\\\/2016\\\/10\\\/Myopia-Care-logo-picto-Large_clear.png\",\"contentUrl\":\"https:\\\/\\\/www.myopiacare.org\\\/wp-content\\\/uploads\\\/2016\\\/10\\\/Myopia-Care-logo-picto-Large_clear.png\",\"width\":1341,\"height\":180,\"caption\":\"myopia.care\"},\"image\":{\"@id\":\"https:\\\/\\\/www.myopiacare.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/myopia.care\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A propos | myopia care","description":"Pascal Blaser and Nick Dash have collaborated to form \u2018myopia.care\u2019 an innovative concept to implementation the risk analysis of children Near-sightednes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/","og_locale":"fr_FR","og_type":"article","og_title":"Test your predicted Level of Myopia (Short-sightedness) with myopia.care","og_description":"'myopia.care' offers a scientific approach to support a clinical pathway for children and young adults at risk of myopia or myopia progression, their parents and eye care professionals. Designed to limit the progression of myopia and its associated potential for sight threatening complications later in life. The web-based utility \u2018myopia.care\u2019 uses predictive myopia risk calculators and a guideline of recommended strategies based on over 50 published, peer reviewed papers and journals.","og_url":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/","og_site_name":"myopia care","article_publisher":"https:\/\/www.facebook.com\/myopia.care\/","article_modified_time":"2020-04-16T18:28:17+00:00","og_image":[{"width":2129,"height":882,"url":"http:\/\/www.myopiacare.org\/wp-content\/uploads\/2016\/10\/kid-behind-table-large-2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_image":"https:\/\/www.myopiacare.org\/wp-content\/uploads\/2016\/10\/myopia-test-kid-behind-table.png","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/","url":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/","name":"A propos | myopia care","isPartOf":{"@id":"https:\/\/www.myopiacare.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/#primaryimage"},"image":{"@id":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/#primaryimage"},"thumbnailUrl":"https:\/\/www.myopiacare.com\/wp-content\/uploads\/2019\/06\/Toolbox.png","datePublished":"2016-10-01T11:43:55+00:00","dateModified":"2020-04-16T18:28:17+00:00","description":"Pascal Blaser and Nick Dash have collaborated to form \u2018myopia.care\u2019 an innovative concept to implementation the risk analysis of children Near-sightednes.","breadcrumb":{"@id":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.myopiacare.org\/fr\/a-propos1\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/#primaryimage","url":"https:\/\/www.myopiacare.com\/wp-content\/uploads\/2019\/06\/Toolbox.png","contentUrl":"https:\/\/www.myopiacare.com\/wp-content\/uploads\/2019\/06\/Toolbox.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.myopiacare.org\/fr\/a-propos1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.myopiacare.org\/fr\/"},{"@type":"ListItem","position":2,"name":"A propos"}]},{"@type":"WebSite","@id":"https:\/\/www.myopiacare.org\/fr\/#website","url":"https:\/\/www.myopiacare.org\/fr\/","name":"myopia care","description":"Test your Predicted Level of Myopia (Short-sightedness)","publisher":{"@id":"https:\/\/www.myopiacare.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.myopiacare.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.myopiacare.org\/fr\/#organization","name":"myopia.care","url":"https:\/\/www.myopiacare.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.myopiacare.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.myopiacare.org\/wp-content\/uploads\/2016\/10\/Myopia-Care-logo-picto-Large_clear.png","contentUrl":"https:\/\/www.myopiacare.org\/wp-content\/uploads\/2016\/10\/Myopia-Care-logo-picto-Large_clear.png","width":1341,"height":180,"caption":"myopia.care"},"image":{"@id":"https:\/\/www.myopiacare.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/myopia.care\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.myopiacare.org\/fr\/wp-json\/wp\/v2\/pages\/361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.myopiacare.org\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.myopiacare.org\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.myopiacare.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.myopiacare.org\/fr\/wp-json\/wp\/v2\/comments?post=361"}],"version-history":[{"count":20,"href":"https:\/\/www.myopiacare.org\/fr\/wp-json\/wp\/v2\/pages\/361\/revisions"}],"predecessor-version":[{"id":1981,"href":"https:\/\/www.myopiacare.org\/fr\/wp-json\/wp\/v2\/pages\/361\/revisions\/1981"}],"wp:attachment":[{"href":"https:\/\/www.myopiacare.org\/fr\/wp-json\/wp\/v2\/media?parent=361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}